The ENEA Tech and Biomedical Foundation has announced a strategic investment of €3 million in VST Srl (Vital Signal in a Touch), an innovative SME founded in 2017 as a spin-off from the University of Modena and Reggio Emilia. This investment aims to support the development and commercialization of Ippocratech® Care, a breakthrough solution for real-time, non-invasive monitoring of five critical vital parameters: heart rate, respiratory rate, body temperature, blood pressure, and blood oxygenation.
These five indicators, alongside consciousness state and skin color, are recognized by the World Health Organization (WHO) as essential markers of an individual’s health status. Ippocratech® Care is designed to facilitate comprehensive health monitoring through an integrated system consisting of a portable device, a mobile application, and medical-grade certified software.
The device enables real-time data acquisition with a single touch, displaying results instantly on the mobile application. The collected data is analyzed by cloud-based artificial intelligence, generating detailed medical reports for precise health monitoring, thus promoting predictive and personalized medicine. Additionally, the solution incorporates a single-lead electrocardiogram (ECG), offering a more comprehensive assessment of an individual’s health condition. The platform securely stores health data in full compliance with GDPR regulations, ensuring the utmost protection of users’ sensitive information.
Matteo Raimondi, President of VST Srl, emphasized the company’s commitment to digital health innovation: “With Ippocratech® Care, we have patented a technology that simultaneously and securely acquires vital data. Our AI-powered mobile application processes and delivers a detailed, user-friendly report. This innovation positions VST as a leader in digital health, aiming for a future where technology empowers individuals to manage their health simply and reliably.”
Maria Cristina Porta, General Director of the ENEA Tech and Biomedical Foundation, highlighted the significance of the investment: “The investment in VST Srl represents a crucial step in supporting cutting-edge technological solutions in the rapidly growing and highly attractive digital health sector. Ippocratech® Care embodies key values such as innovation and preventive healthcare.”
With this strategic investment, VST Srl is poised to accelerate the deployment of its groundbreaking technology, making advanced health monitoring accessible and efficient for individuals and healthcare providers alike.